港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

禮邦醫藥-B

30.280

+4.78018.75%

成交量：127.13萬

成交額：3,713.88萬

市值：102.91億

市盈率：- -

高：31.040

開：26.900

低：26.020

收：25.500

52周最高：46.820

52周最低：22.720

股本：3.40億

香港流通股本：2.27億

量比：0.16

換手率：0.56%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：-33.01%

市淨率：17.69

市盈率(LYR):- -

市銷率: 291.35

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

禮邦醫藥(09637.HK)獲GIC及LAV合計增持逾132萬股涉資近5900萬港元

禮邦醫藥(09637)獲GIC及LAV合計增持逾132萬股涉資近5900萬港元

港股異動 | 禮邦醫藥-B(09637)早盤升逾13% 短期錯殺後股價快速修復 AP301商業化即將落地

異動解讀｜禮邦醫藥-B盤中上漲7.92%，報28.8港元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/09637"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09637","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09637\",,,,,undefined,":{"symbol":"09637","market":"HK","secType":"STK","nameCN":"禮邦醫藥-B","latestPrice":30.28,"timestamp":1783066093492,"preClose":25.5,"halted":0,"volume":1271300,"delay":0,"changeRate":0.1874509803921569,"floatShares":227000000,"shares":339852231,"eps":0,"marketStatus":"已收盤","change":4.78,"latestTime":"07-03 16:08:13","open":26.9,"high":31.04,"low":26.02,"amount":37138772,"amplitude":0.196863,"askPrice":30.28,"askSize":200,"bidPrice":30,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-2.443,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1783301400000},"marketStatusCode":5,"adr":0,"listingDate":1782662400000,"exchange":"SEHK","adjPreClose":25.5,"openAndCloseTimeList":[[1783042200000,1783051200000],[1783054800000,1783065600000]],"volumeRatio":0.162396,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09637\",,,,,undefined,":{"symbol":"09637","floatShares":227000000,"roa":"-33.01%","roe":"--","lyrEps":0,"volumeRatio":0.162396,"shares":339852231,"dividePrice":0,"high":31.04,"amplitude":0.196863,"preClose":25.5,"low":26.02,"week52Low":22.72,"pbRate":"17.69","psRate":"291.35","week52High":46.82,"institutionHeld":0,"latestPrice":30.28,"committee":-0.333333,"eps":0,"divideRate":0,"volume":1271300,"delay":0,"ttmEps":-2.443,"open":26.9,"prevYearClose":22.6,"prevWeekClose":22.6,"prevMonthClose":45.92,"prevQuarterClose":45.92,"fiveDayClose":22.6,"twentyDayClose":22.6,"sixtyDayClose":22.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09637\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09637\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09637\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09637\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09637","date":"2026-07-02","current":-12.394597,"percent":0.666667,"low":-18.066068,"twenty":-18.04018,"median":-14.01511,"eighty":-9.55472,"high":-8.87585,"avg":-13.743035,"sd":4.320048,"marketCap":8666231890},"quantilePoints":[{"date":"2026-06-26","current":-8.87585,"twenty":-8.87585,"median":-8.87585,"eighty":-8.87585,"marketCap":7680660420},{"date":"2026-07-02","current":-10.0073,"twenty":-18.04018,"median":-14.01511,"eighty":-9.55472,"marketCap":8666231890}],"updateTime":1783082866786},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09637\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2648668875","title":"禮邦醫藥(09637.HK)獲GIC及LAV合計增持逾132萬股 涉資近5900萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2648668875","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648668875?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 18:07","pubTimestamp":1783073222,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09637","BK1515","09939","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648668873","title":"禮邦醫藥(09637)獲GIC及LAV合計增持逾132萬股 涉資近5900萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2648668873","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648668873?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 18:07","pubTimestamp":1783073222,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，6月29日，礼邦医药(09637)获两名重要机构股东同步增持。其中，新加坡政府投资公司（GIC Private Limited）以每股44.0844港元增持87.2万股，总金额约3844.16万港元，持股增至1610.03万股，占比7.09%。同日，LAV Asset Management (Hong Kong) Limited以每股45.0615港元增持45万股，涉资约2027.78万港元，持股增至约1634.73万股，占比7.20%。两家机构合计增持逾132万股，累计投入约5872万港元，彰显出对礼邦医药长期价值的认可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462987.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","09939","09637","BK1515","BK1161","BK4104","GIC","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648767637","title":"港股異動 | 禮邦醫藥-B(09637)早盤升逾13% 短期錯殺後股價快速修復 AP301商業化即將落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2648767637","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648767637?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 10:05","pubTimestamp":1783044323,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，礼邦医药-B现涨超13%，截至发稿，涨10.75%，报28.24港元，成交额844.09万港元。据悉，核心产品AP301已进入NDA冲刺阶段，距商业化落地仅12-24个月窗口。值得注意的是，礼邦医药上一交易日股价出现“瀑布杀”，但剔除开盘竞价后，真正把股价砸到26港元下方的连续竞价卖单，合计不足24万股，只占全天827万股成交量的不到3%。向前看，30元为短期阻力位，一旦放量突破并站稳，可以确认修复趋势成立。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","09939","VXUS","09637","BK4588","BK1161","159938","BK4585","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145125055","title":"異動解讀｜禮邦醫藥-B盤中上漲7.92%，報28.8港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145125055","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145125055?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 09:48","pubTimestamp":1783043322,"startTime":"0","endTime":"0","summary":"7月3日，礼邦医药-B盘中上涨7.92%，报28.8港元/股，成交额472.29万港元。礼邦医药成立于2018年，是一家专注肾脏疾病领域的生物制药企业，拥有覆盖高磷血症、肾性贫血、IgA肾病、糖尿病肾病等多适应症的产品管线。核心产品AP301为治疗高磷血症的口服磷结合剂，已完成中国III期注册临床试验，预计近期提交新药上市申请，目前正在中美推进全球III期关键多中心临床试验。公司于6月29日以22.60港元/股的发行价登陆港交所，上市首日收涨103.54%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/09637\",params:#limit:6,delay:false,,,undefined,":[]}}